Definitive Contract 75D30123C16527

Award Date 8/15/23
Potential Completion Date 8/14/25
Potential Value $458K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chapel Hill, NC 27599, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $226,509 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to the University of North Carolina at Chapel Hill (UNC-CH), doing business as the Office of Sponsored Research. The contract is for the "GO NAPSACC" program and has a period of performance through February 21, 2025. UNC-CH, a major public research university, is providing research and professional services to the CDC. The award is not a set-aside contract. UNC-CH has...
This is a $271,640.00 firm fixed price Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the University of North Carolina at Chapel Hill to perform Task A36 under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The award has an 18 month period of performance and does not utilize any set-aside designations. The University of North Carolina at Chapel...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC), which is part of the Department of Health and Human Services (HHS), to the University of North Carolina at Chapel Hill (UNC) for the purchase of specimens. The award was made on September 30, 2018 with a potential value of $112,266.00 and a completion date of November 30, 2020. There was no set-aside designation indicated for this contract. UNC, operating through its Office of Sponsored...
This is a federal contract award to the University of North Carolina at Chapel Hill (UNC-CH) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The $563,541.00 contract is for screening vaccines and other biologics, and is a delivery order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 contract vehicle. The contract has a total ceiling value of $2,254,164.00 and a period of performance...
The U.S. government awarded a $177,629.76 firm fixed-price purchase order to the University of North Carolina at Chapel Hill (UNC-CH), operating under its Office of Sponsored Research, for recruiting services. The contract, which runs until July 31, 2026, was awarded on August 1, 2021 by the Peace Corps, a civilian federal agency. UNC-CH is a major public research university with extensive experience managing large-scale federally-funded projects. The university frequently collaborates with...
The University of North Carolina at Chapel Hill (UNC-CH), through its Office of Sponsored Research, was awarded a $4,521 firm fixed-price purchase order contract by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the U.S. Department of Health and Human Services. The contract, which has a completion date of November 21, 2025, is for the provision of custom adeno-associated virus (AAV) preparations to be used in experiments related to spinal circuits and...
This is a $9,122.52 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of North Carolina at Chapel Hill (UNC-Chapel Hill) on August 12, 2015. The contract has an ultimate completion date of August 31, 2015 and was not set aside for any specific business category. UNC-Chapel Hill is a U.S. state government entity and institution of higher learning that...
This federal contract was awarded by the Department of Veterans Affairs (VA) to the University of North Carolina at Chapel Hill (UNC-Chapel Hill) to conduct suicide prevention research to support VA mental health programs. The contract has a potential value of $523,798. UNC-Chapel Hill, as a U.S. state government entity and institution of higher learning, has received additional federal contracts from the Centers for Disease Control and Prevention (CDC) for online training services and the...
This is a $2,907,745 cost-no-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of North Carolina at Chapel Hill (UNC-CH) to characterize and improve humanized immune system mouse models for infectious disease research. The contract supports NIAID's efforts to develop medical countermeasures against emerging infectious diseases and antimicrobial resistance. The contract was awarded under NIAID's $146.3 million single-award...
This $6,674.40 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to the University of North Carolina at Chapel Hill (UNC-Chapel Hill). The contract is for Tier 2 analysis by liquid chromatography-tandem mass spectrometry (LC-MS/MS) of 72 macaque plasma samples. The contract has a completion date of May 15, 2024 and does not have a...

The University of North Carolina at Chapel Hill, operating through its Office of Sponsored Research, has been awarded a $457,586 firm fixed price definitive contract from the Centers for Disease Control and Prevention located in Pittsburgh, Pennsylvania. The contract calls for UNC-Chapel Hill to deliver an implant carrier containing polymeric solid implants with the drugs Rilpivirine and Cabotegravir or an analogue, to be used by CDC in research to prevent and treat HIV infection. The original sole source solicitation sought these implants to be tested for integrity, migration, and drug concentrations in mice models. As the current contractor and sole identified source able to meet requirements, UNC-Chapel Hill will define implant integrity over time, body migration, and minimum effective drug concentrations in blood plasma under this new contract performance period spanning from August 2023 through August 2025.

Generated 12/29/23, 4:14 PM